Earlier this month, Gilead Sciences announced that it had signed non-exclusive, royalty-free voluntary licensing agreements… The post Gilead to support generic lenacapavir in low-income nations first appeared on beyondpositive. [...]
HIV and sexual health activists protested today at Gilead Sciences’ London Office demanding the company… The post Activists demand global access to HIV prevention drug first appeared on beyondpositive. [...]
New data from the PURPOSE 2 study shows that twice-yearly lenacapavir is 89% more effective… The post Twice-yearly lenacapavir 89% more effective than Truvada first appeared on beyondpositive. [...]
Australian sexual health and HIV organisations are sending out reminders for PrEP users to “plan… The post Concern as PrEP supplies run low in Australia first appeared on beyondpositive. [...]
HEADLINES
Opt-out testing for HIV and hepatitis begins in Birmingham emergency departments
The roll-out of opt-out testing across forty-seven sites nationwide hits the West Midlands today. All patients aged 16 and over attending the emergency department at Birmingham's Queen Elizabeth Hospital will…
Read More
FOLLOW US ON OUR SOCIALS
